Innovations and Trends in Beta Thalassemia Treatment Beta thalassemia, a genetic blood disorder characterized by insufficient production of hemoglobin, poses significant challenges for affected individuals and the healthcare system. Historically, treatment options have been limited, relying heavily on blood transfusions and iron chelation therapy. However, recent advancements and innovations are transforming the landscape of Beta Thalassemia treatment. For More https://www.delveinsight.com/report-store/beta-thalassemia-market